Works matching IS 10781552 AND DT 2023 AND VI 29 AND IP 3
Results: 34
Newly approved and forthcoming T-cell-redirecting bispecific antibodies for the treatment of relapsed/refractory multiple myeloma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 3, p. 722, doi. 10.1177/10781552231154809
- By:
- Publication type:
- Article
Comment on 'risk factors associated with nausea and vomiting in children with cancer receiving chemotherapy'.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Ocular toxicity following carboplatin chemotherapy for neuroendocrine tumour of the bladder.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 3, p. 768, doi. 10.1177/10781552221122005
- By:
- Publication type:
- Article
Nivolumab–ipilimumab combination therapy-induced seronegative encephalitis; rapid response to steroid plus intravenous immunoglobulin (IVIG) treatment.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 3, p. 760, doi. 10.1177/10781552221118529
- By:
- Publication type:
- Article
A review of medical devices used for safe chemotherapy applications: Focus on ONCOERA ® IV GROUP products.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 3, p. 709, doi. 10.1177/10781552221147694
- By:
- Publication type:
- Article
A practical method for oral administration of isotretinoin in pediatric oncology patient: A case study of neuroblastoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 3, p. 755, doi. 10.1177/10781552221117814
- By:
- Publication type:
- Article
Response to comment on "Risk factors associated with nausea and vomiting in children with cancer receiving chemotherapy".
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 3, p. 520, doi. 10.1177/10781552231152783
- By:
- Publication type:
- Article
Critical appraisal of clinical guidelines for prevention and management of doxorubicin-induced cardiotoxicity.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 3, p. 695, doi. 10.1177/10781552221147660
- By:
- Publication type:
- Article
Intravenous route for folate supplementation in a patient with celiac disease treated by pemetrexed-based chemotherapy for non-small-cell lung cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 3, p. 750, doi. 10.1177/10781552221117734
- By:
- Publication type:
- Article
Capecitabine-related neurotoxicity presenting with agraphia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 3, p. 746, doi. 10.1177/10781552221116329
- By:
- Publication type:
- Article
Mild forms of thrombotic microangiopathy in patients with advanced pancreatic cancer receiving gemcitabine and nab-paclitaxel.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 3, p. 738, doi. 10.1177/10781552221114653
- By:
- Publication type:
- Article
Severe acute radiation dermatitis after palbociclib therapy in the setting of palliative radiotherapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 3, p. 764, doi. 10.1177/10781552221118841
- By:
- Publication type:
- Article
Pinnae and facial hypertrichosis induced by cetuximab.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 3, p. 731, doi. 10.1177/10781552221114073
- By:
- Publication type:
- Article
Anaphylaxis caused by pegylated recombinant human granulocyte colony-stimulating factor.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 3, p. 727, doi. 10.1177/10781552221112323
- By:
- Publication type:
- Article
Development of a decision tree for the pharmacy-led consultation of elderly patients with haematological malignancies.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 3, p. 685, doi. 10.1177/10781552221080419
- By:
- Publication type:
- Article
Evaluation of a pediatric pre-chemotherapy rapid hydration protocol: A quality assurance project.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 3, p. 679, doi. 10.1177/10781552221078207
- By:
- Publication type:
- Article
Prevalence and risk factors of trastuzumab induced cardiotoxicity in Tunisian HER2-positive breast cancer patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 3, p. 613, doi. 10.1177/10781552221076407
- By:
- Publication type:
- Article
Health care seeking behaviors and perspective on indigenous palliative care among cancer patients in Kenya.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 3, p. 669, doi. 10.1177/10781552221078204
- By:
- Publication type:
- Article
A pilot study to explore societal, patient, and public authority perception on 'Value-Added Tax' system for healthcare financing in Zimbabwe: A case for cancer treatment.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 3, p. 603, doi. 10.1177/10781552221075543
- By:
- Publication type:
- Article
A cost analysis of sorafenib for desmoid tumors.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 3, p. 663, doi. 10.1177/10781552221077927
- By:
- Publication type:
- Article
The physical exam's role in determining dose-limiting toxicity prior to immunochemotherapy administration in lymphoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 3, p. 601, doi. 10.1177/10781552221075224
- By:
- Publication type:
- Article
Investigating the efficacy of osimertinib and crizotinib in phase 3 clinical trials on anti-cancer treatment-induced cardiotoxicity: are real-world studies the way forward?
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 3, p. 646, doi. 10.1177/10781552221077417
- By:
- Publication type:
- Article
Physicochemical stability of PF-05280014 (trastuzumab-qyyp; Trazimera TM), a trastuzumab biosimilar, under extended in-use conditions.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 3, p. 590, doi. 10.1177/10781552221074649
- By:
- Publication type:
- Article
The association between patient satisfaction with information and adherence to oral anticancer agents.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 3, p. 637, doi. 10.1177/10781552221077258
- By:
- Publication type:
- Article
Poor tolerability of lenvatinib in elderly patients ≥80 years old with hepatocellular carcinoma: A multicenter observational study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 3, p. 626, doi. 10.1177/10781552221077039
- By:
- Publication type:
- Article
Duration of sweat cyclophosphamide excretion in patients undergoing a conditioning regimen of high-dose cyclophosphamide for hematopoietic stem-cell transplantation.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 3, p. 619, doi. 10.1177/10781552221077035
- By:
- Publication type:
- Article
A retrospective analysis of first-line PD-1 monoclonal antibodies treatment in patients with leptomeningeal metastasis from solid tumors.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 3, p. 582, doi. 10.1177/10781552221074622
- By:
- Publication type:
- Article
Retrospective study evaluating immune-related adverse events in cancer patients treated with pembrolizumab.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 3, p. 577, doi. 10.1177/10781552221074374
- By:
- Publication type:
- Article
A comprehensive evaluation of the safety of ipilimumab, nivolumab and their combination therapy: A systematic review and network meta-analysis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 3, p. 557, doi. 10.1177/10781552221074315
- By:
- Publication type:
- Article
Assessment of Imatinib as a Primary Treatment of Chronic Myeloid Leukemia in Chronic Phase: a Cohort Study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 3, p. 547, doi. 10.1177/10781552221074272
- By:
- Publication type:
- Article
Evaluation of awareness about importance of high fever in leukemia and lymphoma patients receiving chemotherapy among healthcare professionals working in pharmacies other than hospital pharmacies: A survey from a Central Anatolian city.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 3, p. 543, doi. 10.1177/10781552221074045
- By:
- Publication type:
- Article
QTc prolongation during levofloxacin and triazole combination chemoprophylaxis: Prevalence and predisposing risk factors in a cohort of hematopoietic cell transplantation recipients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 3, p. 534, doi. 10.1177/10781552221074016
- By:
- Publication type:
- Article
Pro-adherence complementary audiovisual educational intervention model for chronic myeloid leukemia patients treated with imatinib mesylate.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 3, p. 521, doi. 10.1177/10781552211073894
- By:
- Publication type:
- Article
Chemotherapy-induced neutropenia among breast Cancer patients in a tertiary care hospital: Risk and consequences.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 3, p. 529, doi. 10.1177/10781552221074004
- By:
- Publication type:
- Article